cholest-5-ene-3,4-diol has been researched along with Diabetes Mellitus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diczfalusy, U; Mannheimer, B; Östenson, CG; Wagner, H | 1 |
1 trial(s) available for cholest-5-ene-3,4-diol and Diabetes Mellitus
Article | Year |
---|---|
No impact of vitamin D on the CYP3A biomarker 4β-hydroxycholesterol in patients with abnormal glucose regulation.
Topics: Aged; Biomarkers; Blood Glucose; Body Mass Index; Cholesterol; Cytochrome P-450 CYP3A; Diabetes Mellitus; Double-Blind Method; Fasting; Female; Gene Expression; Glucose Tolerance Test; Humans; Hydroxycholesterols; Insulin Resistance; Liver; Male; Middle Aged; Vitamin D | 2015 |